Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. The solutions that the company offers include haematology, haemostasis, and urinalysis analyzers. It conducts research and development at its facilities in Japan, New Zealand, France, Germany and the US. The company operates along with its subsidiaries in the Americas, Europe, the Middle East, Africa and Asia Pacific. Its products are used by medical institutions. Sysmex is headquartered in Hyogo, Japan.
Headquarters
Japan
Address
1-5-1, Wakinohama Kaigandori, Chuo-Ku, Kobe-Shi, Hyogo, 651-0073
Website
www.sysmex.co.jp
Telephone
81 78 2650500
No of Employees
8,445
Industry
Medical Equipment
Ticker Symbol & Exchange
6869 (TYO)
Revenue (2022)
$3.2B
EPS
XXX
Market Cap*
$12.1B
Net Profit Margin (2021)
XXX
-6.0%
* As of and is in US$
Explore premium data & analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Haematology | Medical Services | Sysmex |
| XN-series | After-Sales Services | |
| XT-series Systemisation | ||
| XXX | ||
| XXX | ||
| XXX |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2022 | Acquisitions/Mergers/Takeovers | In May, the company acquired Astrego Diagnostics AB and changed its name to Sysmex Astrego AB. |
| 2022 | Contracts/Agreements | In February, the company formed a capital and business tie-up with KAINOS Laboratories, Inc. to develop and produce diagnostic reagents in the immunochemistry field. |
| 2022 | Corporate Changes/Expansions | In February, the company announced the establishment of a new subsidiary, Sysmex LLC in Saudi Arabia. |
Competitor Comparison
| Key Parameters | Sysmex Corp | F. Hoffmann-La Roche Ltd | Siemens Healthineers AG | Becton Dickinson and Co | bioMerieux SA |
|---|---|---|---|---|---|
| Headquarters | Japan | Switzerland | Germany | United States of America | France |
| City | Kobe-Shi | Basel | Erlangen | Franklin Lakes | Craponne |
| State/Province | Hyogo | - | - | New Jersey | - |
| No. of Employees | 8,445 | 100,920 | 66,800 | 75,000 | 13,076 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Operating Margin
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Hisashi Ietsugu | Chairman; Chief Executive Officer | Executive Board | 2013 | - |
| Kaoru Asano | Senior Managing Director; Senior Executive Officer; Director; Chief Technology Officer | Executive Board | 2017 | - |
| Iwane Matsui | Senior Executive Officer; Managing Director; Director | Executive Board | - | - |
| Hiroshi Kanda | Managing Director; Director; Senior Executive Officer | Executive Board | - | - |
| Kenji Tachibana | Senior Managing Director; Director; Senior Executive Officer | Executive Board | 2017 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer